Siegfried's positive results were driven by continued high demand for our products and services, ongoing active portfolio optimization and a strong focus on operational excellence and efficiency at all manufacturing sites. Discover more: https://lnkd.in/d8uTrPfj #mediarelease #halfyearresults #continousgrowth
Siegfried
Arzneimittelherstellung
Zofingen, Aargau 28.386 Follower:innen
Expect more
Info
Expect more with Siegfried as your preferred partner. Siegfried is a preferred manufacturing and service partner in the global pharmaceutical industry. Our company is looking back on more than 150 years of unmatched quality and combines both chemistry and pharmaceutics under one roof. We develop and manufacture active pharmaceutical ingredients for pharmaceutical clients with R&D programs, related intermediates and controlled substances. Siegfried also offers development and production of finished dosage forms, including sterile fillings. Approximately 3600 dedicated employees in Switzerland, Germany, France, Spain, Malta, China and the USA establish innovative and integrated solutions for our customers that bring a significant added value.
- Website
-
http://www.siegfried.ch
Externer Link zu Siegfried
- Branche
- Arzneimittelherstellung
- Größe
- 1.001–5.000 Beschäftigte
- Hauptsitz
- Zofingen, Aargau
- Art
- Kapitalgesellschaft (AG, GmbH, UG etc.)
- Gegründet
- 1873
- Spezialgebiete
- Formulation Development, Analytical Development, Solid Dosage Forms, Parenterals (vials, ampoules, cartridges, syringes), Ophtalmics (liquids and semisolids), API, Active Pharmaceutical Ingredient, Exclusive Synthesis, High Potency, Intermediates, Sterile Filling, biologics finished dosage forms und spray drying
Orte
Beschäftigte von Siegfried
Updates
-
In the first half of 2024, Siegfried continued its journey of profitable growth. Significant progress has been made in the implementation of the corporate strategy EVOLVE which is geared towards long-term profitable growth in core areas and beyond. Read the media release: https://lnkd.in/dbkaRmh6 #growth #profitability #halfyearresults #mediarelease
-
We are proud to see our Zofingen team continue to grow.
HR Professional with heart | Supporting the companies growth and inspiring employees to perform their best | HR Passionate | Talent Spotter | Outdoor Addict
I am thrilled to announce that our #strongestteam 🥇 at #Siegfried is growing 👏 On our Welcome Day we have onboarded 13 new colleagues. Once again, I would like to welcome you on board and wish you an amazing ride and a lot of success 🍀🚀 You want to join us? Check out our openings and hope to see you soon! https://lnkd.in/ekB2eEtf
-
-
Meet Gerard, who celebrates 15 years with Siegfried in August! Throughout the years, Siegfried has been instrumental in his professional growth and he remains excited for the next chapter. Curious to read about Gerard's testament of transformation and growth? Dive into the full story here: https://lnkd.in/dn9u2KH9 #EmployeeAmbassador #Teamwork #ContinuousLearning #CareerGrowth #Community
-
-
As a CDMO, achieving ambitious sustainability targets requires close collaboration with customers and suppliers. Join Luca Dalla Torre's presentation on the final day of ChemOutsourcing Week to learn how Siegfried balances stakeholder expectations and customer engagement to progress on our sustainability efforts. https://lnkd.in/gNPjVz9T #Expertise #SustainabilityLeaders #CDMO #ChemOutsourcing #SustainablePharma
-
-
The molecules entering the pharmaceutical pipeline are getting more and more complex. For example, the number of chemical steps involved in making an Active Pharmaceutical Ingredient (API) has nearly doubled in the past 20 years. At the same time, we also see that accelerated approval timelines are pretty much the new normal. All of these factors come together to create a huge amount of complexity. How to navigate this increasing complexity in pharmaceutical manufacturing? Head to our blog: https://lnkd.in/dyqtmtax #PharmaceuticalManufacturing #Pharmaceuticals #Pharma #PharmaIndustry
How to navigate the increasing complexity in pharma manufacturing
-
In line with Siegfried's commitment to reducing our carbon footprint by 50% by 2030, Siegfried Barberà launched a project to install more than 6,800m2 of solar panels on its buildings. This installation will generate more than 1.8 GWh of renewable energy per year for self-consumption, saving 1,500 tons of CO2 emissions yearly. Another step forward on our sustainability journey! #SustainablityLeader #RenewableEnergy #SolarEnergy
-
-
At Siegfried, we're committed to enhancing the environmental performance of our API production processes. With our newly launched sustainability dashboard, we're making concrete steps to achieve this goal. This powerful strategic tool provides a process overview based on key indicators of environmental burden. It allows us to make data-driven decisions, prioritize improvement projects for maximum impact, set ambitious green chemistry goals, and continuously improve our environmental footprint, and we're already seeing promising results. Visit our website to learn more about our sustainability journey: https://lnkd.in/dKTm7trf #SustainablePharmaceuticals #GreenChemistry #APIManufacturing #Sustainability #PharmaTech
-
-
Patient safety demands that any injectable medicine must remain sterile. How do we go about designing such a container closure system, and how do we test that it remains sterile? Read the blog to learn more: https://lnkd.in/gNHiPHs7 #expertise #steriles #containerclosure #blog
-
-
Today on the United Nations World Youth Skills day, meet Ravivan who started her career with Siegfried as a commercial apprentice in 2014. Throughout her journey, she has grown and evolved within the company. Want to learn more about Ravivan's experience? Check out her full story: https://lnkd.in/dhKHYqJK #EmployeeAmbassador #ContinuousLearning #CareerGrowth #Apprenticeship #YouthSkills
-